Eight mouse monoclonal antibodies specific for hepatitis B surface antigen (HBsAg) were examined for their effects on the antigen-induced proliferative response and lymphokine production of human HBsAg-specific T-cell clones in vitro. While all specifically enhanced the T-cell proliferative response, antibodies of the IgG class were generally more effective than those of the IgM class. Both the divalent F(ab')2 and the monovalent Fab fragments of an IgG monoclonal antibody had no effects, indicating that the Fc portion of the antibody molecules was required. Since antigen-presenting cells bear surface receptors for the Fc of IgGs and fewer or none for that of IgMs, the above results also suggest that antibodies enhance the capture of antigens by antigen-presenting cells as a result of the binding of antigen-antibody complexes to the Fc receptors on these cells. In addition to potentiating the proliferation of the T-cell clones, antibodies also increased the antigen-induced production of interferon-y by these cells. The present in vitro studies suggest that antibodies may regulate immune responses and do so by enhancing antigen presentation and thus augmenting antigen-induced activation and clonal expansion of T cells.
ABSTRACT
Eight mouse monoclonal antibodies specific for hepatitis B surface antigen (HBsAg) were examined for their effects on the antigen-induced proliferative response and lymphokine production of human HBsAg-specific T-cell clones in vitro. While all specifically enhanced the T-cell proliferative response, antibodies of the IgG class were generally more effective than those of the IgM class. Both the divalent F(ab')2 and the monovalent Fab fragments of an IgG monoclonal antibody had no effects, indicating that the Fc portion of the antibody molecules was required. Since antigen-presenting cells bear surface receptors for the Fc of IgGs and fewer or none for that of IgMs, the above results also suggest that antibodies enhance the capture of antigens by antigen-presenting cells as a result of the binding of antigen-antibody complexes to the Fc receptors on these cells. In addition to potentiating the proliferation of the T-cell clones, antibodies also increased the antigen-induced production of interferon-y by these cells. The present in vitro studies suggest that antibodies may regulate immune responses and do so by enhancing antigen presentation and thus augmenting antigen-induced activation and clonal expansion of T cells.
to HBsAg were isolated from the PBM of vaccine recipients by in vitro antigen stimulation in the presence of IL-2 (13) . These cells proliferated specifically to HBsAg and produced increased amounts of interferon-y (IFN-y) and B-cell growth factor (36) . Furthermore, at least two clones were found to be capable of promoting the in vitro production of antibodies to HBsAg (anti-HBs) by autologous B lymphocytes (13) .
We have also studied the effects of antigen-specific antibodies, end products of the immune pathways, on the response of the regulatory T cells to the antigen. We observed earlier that purified anti-HBs from plasma of hepatitis B vaccine recipients specifically potentiated the antigen-induced proliferation of HBsAg-specific T-cell clones (14) . We report here the effects of mouse monoclonal antibodies specific for HBsAg on the antigen-induced proliferation and IFN-y production of human T-cell clones. We analyzed the effects of the different immunoglobulin classes and subclasses of the monoclonal antibodies and the requirement of the Fc portion of antibodies on the proliferative response of T cells to antigen. These studies may provide answers to the possible mechanism of the interesting antibody effect on T cells. (15) . HBsAg derived from human plasma and culture supernatant were purified by affinity chromatography using the mouse monoclonal IgM antibody H5D3 specific for HBsAg conjugated to agarose beads (Affi-Gel 10, Bio-Rad) as described (16 Antibodies. Mouse monoclonal anti-HBs were prepared by somatic cell hybridization techniques as described (18) . The mouse monoclonal antibody B2TT, specific for tetanus toxoid, was also used (19) . Ascitic fluids containing 5-20 mg of specific antibodies per ml were used in most experiments. The amount of specific anti-HBs in each ascitic fluid was determined by a radioimmunoassay using HBsAg-coated polyvinyl 96-well plates, and 125I-labeled goat anti-mouse IgG or goat anti-mouse IgM. The antigen binding activity in the ascitic fluids was compared with standard curves using purified monoclonal anti-HBs IgG (A5C3) or monoclonal anti-HBs IgM (H5D3). The monoclonal anti-HBs A5C3 (IgG2a) was purified from ascitic fluid by affinity chromatography on protein A Sepharose (Sigma). F(ab')2 and Fab fragments of A5C3 were prepared by digestion with pepsin and papain, respectively, as described (20, 21 (Costar) . Supernatants were removed, filtered through a 0.2-pm pore membrane, and assayed for IFN-y using an immunoradiometric assay developed in our laboratory (22) . Quantitation of IFN-y was done using a standard curve with DEAE-purified IFN-y derived from mitogen-activated human PBM. The sensitivity of this assay was -0.1 NIH unit of IFN-y per ml.
RESULTS
Eight mouse monoclonal antibodies specific for HBsAg were examined for their effects on the antigen-induced proliferation and immune factor production of three human HBsAg-specific T-cell clones. Two of these clones, HBC-6 and HBC-13, were shown to promote the production of antiHBs by autologous B cells. The other two clones, HBC-1 and HBC-4, were also OKT4' OKT8-, but their functions
are not yet known (13) . Fig. 1 shows the results obtained with a constant concentration (1 jug/ml) of these monoclonal anti-HBs on the proliferative response of a helper T-cell clone to different antigen concentrations. All of the monoclonal anti-HBs of IgG class (three IgG1 and two IgG2a) significantly increased the proliferation of HBC-13 to HBsAg.
However, the effect of monoclonal anti-HBs of IgM class was far less dramatic than that of the antibodies of IgG class. Of the three monoclonal IgM anti-HBs tested, two increased the HBsAg-induced proliferation to a small extent at high antigen concentrations. A monoclonal anti-tetanus toxoid IgG did not affect the HBsAg-induced proliferation of the Tcell clone.
In a separate experiment using HBC-6 another helper Tcell clone, six of the monoclonal anti-HBs were studied at different concentrations for their effect on the antigen-in- duced proliferative response at a constant concentration of HBsAg (1 jig/ml). The titration curves presented in Fig. 2 show that the four monoclonal IgG anti-HBs (two IgG1 and two IgG2a) tested were effective in enhancing the proliferation of the T cells to HBsAg over a wide range of antibody concentrations. On the other hand, in this experiment, no significant enhancement of the HBsAg-induced proliferation was observed at any concentration of the monoclonal antiHBs of IgM class tested. As with HBC-13, the anti-tetanus toxoid IgG mouse monoclonal antibody had no effect on the antigen-induced proliferation of this T-cell clone.
The potentiating effect of one of the (IgG1) monoclonal anti-HBs on the antigen-induced proliferation of cloned T cells was also examined using two purer preparations of HBsAg, which do not contain human serum proteins. One preparation (pepsin/urea-treated HBsAg) was also derived from plasma of chronic carriers but was treated with pepsin and urea to remove the complexed human serum proteins and it is very similar to the Hepatavax-B (Merck Sharp & Dohme) vaccine (17) . The other HBsAg preparation (LSVHBsAg) was purified from the culture supernatant of a genetically engineered cell line that harbored and expressed DNA encoding HBsAg. The results presented in Fig. 3 show that the monoclonal IgG anti-HBs was also effective in enhancing the proliferation of HBC-6 cells to both of these HBsAg preparations.
The effects of anti-HBs on the antigen-induced production of IFN-y, an important immunoregulatory and effector lymphokine, by HBsAg-specific T cells were also examined. The data presented in Table 1 indicate that, in all cases, significantly more IFN-y was secreted by the three HBsAgspecific T-cell clones and by one HBsAg-specific T-cell line when both an IgG anti-HBs and HBsAg were present in the cultures than when antigen alone was used. In the absence of antigen, the anti-HBs slightly increased the production of IFN-y.
The role of the Fc portion of the antibody molecule in the potentiation of the response of T cells to HBsAg was addressed. Fig. 4 shows that only intact anti-HBs IgG molecules were capable of enhancing the HBsAg-induced proliferation of HBC-6 cells. Both the F(ab')2 and Fab fragments (24) (25) (26) .
Some early studies by Cohen et al. (27, 28) showed that sera from immune animals enhanced the proliferation of guinea pig peritoneal exudate lymphocytes to antigen in vitro.
The present studies were designed to explore the mechanisms of this effect of antibodies on T-cell activity. The results indicate that all of the monoclonal anti-HBs of IgG class studied increased the antigen-induced proliferation of HBsAg-specific T-cell clones ( Figs. 1 and 2 ). No significant difference was observed between the anti-HBs of IgG1 and IgG2a. This antibody effect also occurred with purer HBsAg preparations that did not contain serum proteins (Fig. 3) . The IgM monoclonal anti-HBs were in general not as effective in enhancing the proliferative responses of the T cells to HBsAg (Figs. 1 and 2) . Finally, our results also showed clearly that the Fc portion of the IgG anti-HBs was absolutely required for the antibodies to potentiate the proliferation of the cloned T cells to HBsAg (Fig. 4) .
Since IgM antibodies should aggregate or polymerize antigens as well as or even better than IgG antibodies, and since the divalent F(ab')2 fragments of IgG should still aggregate antigens like the intact IgG molecules, the above results suggest that aggregation of antigens per se was not the major factor accounting for the ability of the antibody to enhance the antigen-induced T-cell proliferation. The results do suggest that the Fc receptors on antigen-presenting cells, such as monocytes, were involved. The antibody-antigen complexes bind to Fc receptors on the antigen-presenting cells, and the F(ab')2 fragments lose the ability to do so because the Fc portion has been cleaved. If this suggestion is correct, the Fc receptors for IgGs must be more abundant or more effective than those for IgMs or, alternatively, the antigenpresenting cells with IgG Fc receptors should be more numerous than those with IgM Fc receptors. In fact, the presence of Fc receptors for IgG1 and IgG2 on some antigenpresenting cells has been well established, but that for IgM still remains controversial (24) (25) (26) 29) . The potentiating effect of antibodies on antigen-induced proliferation is not only restricted to HBsAg, and it probably occurs generally with a variety of antigens. We recently observed that both human polyclonal and mouse monoclonal anti-tetanus toxoid antibodies were effective in enhancing the antigen-induced proliferative response of human T cells specific for tetanus toxoid (unpublished results).
Although antigen-induced proliferation appears to be an adequate way of measuring T-cell activation, it does not measure T-cell effector or regulatory functions. The finding that monoclonal IgG anti-HBs also increased significantly the amounts of IFN-y secreted by three HBsAg-reactive Tcell clones and one line upon antigenic stimulation (Table 1) indicates that not only proliferation but also effector function of T cells can be modulated by these antibodies.
The present observations suggest that antibody is an important element involved in the regulation of immune responses. It does so by potentiating the antigen-induced expansion of T-cell clones and the generation of effector functions. Our results from the in vitro studies may provide an explanation for the effects of antibodies in the immune response in whole animals. Numerous reports have appeared in the past two decades describing the effects of immune complexes and passively administered antibodies in potentiating or inhibiting in vivo-generated immune responses to some antigens (30) (31) (32) . For example, Terres and co-workers (33, 34) 
